Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms
Mounting evidence suggests safety and efficacy of psychedelic compounds as potential
novel therapeutics in psychiatry. Ketamine has been approved by the Food and Drug …
novel therapeutics in psychiatry. Ketamine has been approved by the Food and Drug …
VDAC, a multi-functional mitochondrial protein regulating cell life and death
V Shoshan-Barmatz, V De Pinto, M Zweckstetter… - Molecular aspects of …, 2010 - Elsevier
Research over the past decade has extended the prevailing view of the mitochondrion to
include functions well beyond the generation of cellular energy. It is now recognized that …
include functions well beyond the generation of cellular energy. It is now recognized that …
Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms
Amphetamine-related drugs, such as 3, 4-methylenedioxymethamphetamine (MDMA) and
methamphetamine (METH), are popular recreational psychostimulants. Several preclinical …
methamphetamine (METH), are popular recreational psychostimulants. Several preclinical …
The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA,“ecstasy”)
AR Green, AO Mechan, JM Elliott, E O'Shea… - Pharmacological …, 2003 - Elsevier
Abstract The amphetamine derivative (±)-3, 4-methylenedioxymethamphetamine (MDMA,
ecstasy) is a popular recreational drug among young people, particularly those involved in …
ecstasy) is a popular recreational drug among young people, particularly those involved in …
Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview
Abstract “Ecstasy”[(±)-3, 4-methylenedioxymethamphetamine, MDMA, XTC, X, E] is a
psychoactive recreational hallucinogenic substance and a major worldwide drug of abuse …
psychoactive recreational hallucinogenic substance and a major worldwide drug of abuse …
The serotonergic system in Parkinson's disease
Although the cardinal manifestations of Parkinson's disease (PD) are attributed to a decline
in dopamine levels in the striatum, a breadth of non-motor features and treatment-related …
in dopamine levels in the striatum, a breadth of non-motor features and treatment-related …
Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms
J Lyles, JL Cadet - Brain Research Reviews, 2003 - Elsevier
Methylenedioxymethamphetamine (MDMA, Ecstasy) is a very popular drug of abuse. This
has led to new intense concerns relevant to its nefarious neuropsychiatric effects. These …
has led to new intense concerns relevant to its nefarious neuropsychiatric effects. These …
The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and d-amphetamine
Abstract Amphetamine ('Speed'), methamphetamine ('Ice') and its congener 3, 4-
methylenedioxymethamphetamine (MDMA;'Ecstasy') are illicit drugs abused worldwide for …
methylenedioxymethamphetamine (MDMA;'Ecstasy') are illicit drugs abused worldwide for …
Kinetics, mechanism, and inhibition of monoamine oxidase
Monoamine oxidases (MAOs) catalyse the oxidation of neurotransmitter amines and a wide
variety of primary, secondary and tertiary amine xenobiotics, including therapeutic drugs …
variety of primary, secondary and tertiary amine xenobiotics, including therapeutic drugs …
Dark classics in chemical neuroscience: 3, 4-methylenedioxymethamphetamine
LE Dunlap, AM Andrews, DE Olson - ACS chemical neuroscience, 2018 - ACS Publications
Better known as “ecstasy”, 3, 4-methylenedioxymethamphetamine (MDMA) is a small
molecule that has played a prominent role in defining the ethos of today's teenagers and …
molecule that has played a prominent role in defining the ethos of today's teenagers and …